Afon Technology is revolutionising diabetes care with its innovative GlucowearTM – the world’s first non-invasive, real-time continuous glucose monitor. Company CEO, Sabih Chaudhry, explains how the technology is being recognised and developed
Afon Technology is redefining diabetes care with GlucowearTM – the world’s first non-invasive, real-time continuous glucose monitor. Born in Wales, this groundbreaking innovation is capturing attention across Europe for its seamless blend of advanced technology and user-friendly design, offering a transformative solution for millions
of people managing diabetes.
Glucowear is designed to be worn comfortably on the underside of the wrist, built right into a watch strap. It connects easily to a smartphone via Bluetooth, giving users instant access to real-time glucose data. Using safe, low-power RF/microwave technology to monitor blood sugar levels removes the need for finger pricks, making diabetes management easier, more consistent, and far less intrusive.
In the fast-evolving landscape of health technology, Afon Technology stands out as a trailblazer, driving a new age of personalised diabetes care. At the intersection of innovation and healthcare, Glucowear is setting a new standard, redefining what’s possible and reshaping the future of diabetes management worldwide.
European funding boost
Afon Technology has taken a significant leap forward in its mission to transform diabetes management, thanks to substantial support from Horizon Europe – the EU’s largest and most prestigious research and innovation programme.
The pioneering company has been awarded over €2 million in funding to accelerate the development of its Glucowear device. This financial backing from Horizon Europe, part of a wider €80 billion initiative, underscores the global potential of Afon’s innovation.
Sabih Chaudhry, CEO of Afon Technology, said: “From our small office and laboratory in Wales, our skilled team is pursuing the holy grail of glucose monitoring and a breakthrough with the potential to change the world of diabetes.
“The Horizon funding scheme has been instrumental in accelerating the development of our groundbreaking technology. This funding allows us to drive our innovation toward commercialisation and, ultimately, improve the lives of those living with diabetes.”
As Afon Technology pushes the boundaries of non-invasive monitoring, its success highlights the critical role of international collaboration and public funding in advancing life-changing medical technologies. With global tech giants like Apple, Samsung, and Google reportedly exploring similar technology, yet none reaching viable clinical outcomes, Afon Technology is leading the race toward a future where managing diabetes is simpler, safer, and completely needle-free.
Repeat success for new designs
Recently, Afon Technology has celebrated another major milestone in its journey to revolutionise diabetes care, with Glucowear once again receiving international acclaim for its innovative design. The company’s non-invasive continuous glucose monitoring device has claimed victory at the prestigious European Product Design Awards for a second time, this year in the category of Personal/ Wellness and Beauty: Other Designs.
This repeat recognition reflects the creative brilliance behind Glucowear, brought to life through a close collaboration with Cardiff-based consultancy, Medical Design Group Ltd. Led by designer Tom Craven, the team combined cutting-edge functionality with sleek, user-focused aesthetics, creating a wearable that not only performs at the highest level but also fits effortlessly into daily life.
Beyond its technological innovation, the Glucowear device’s intuitive and refined design is being hailed as a benchmark for the future of wearable healthcare devices. This latest accolade adds to Afon Technology’s growing list of honours, including a Health and Safety Gold Award, which recognises the company’s commitment to excellence in both innovation and workplace wellbeing.
A look back
Over the past several years, the field of diabetes technology has emerged as a transformative force in global healthcare, playing a crucial role in improving and extending the lives of millions of people living with diabetes. From the development of sophisticated insulin delivery systems to the widespread adoption of continuous glucose monitoring (CGM) devices, innovation in this area has dramatically shifted the way diabetes is managed on a daily basis.
No longer is diabetes seen solely as a life-threatening condition. Today, with the right tools and technologies, it is increasingly viewed as a chronic illness that can be effectively controlled. The past decade, in particular, has brought forth a wave of groundbreaking advances.
These include the integration of Artificial Intelligence into the prediction of blood sugar trends, the advent of hybrid closed-loop systems often referred to as ‘artificial pancreas’ technology, and the growing accessibility of mobile health applications that empower individuals to take charge of their own care. These innovations have not only improved clinical outcomes but have also enhanced the overall quality of life for people, allowing them to live more freely, confidently, and healthily.
Afon Technology continues to stand at the forefront of innovation with the creation of its non-invasive glucose monitor. Glucowear goes beyond conventional features; it integrates cutting-edge technology to monitor glucose levels continuously and non-invasively.
With Glucowear on their wrist, users can enjoy uninterrupted tracking and recording of their blood glucose levels. The device continuously monitors glucose levels, ensuring that data is captured in real time without any breaks, providing a reliable and accurate picture of blood sugar fluctuations throughout the day.
The road ahead for diabetes monitoring
As innovation accelerates across the field, the launch of Glucowear marks a significant step toward a future where managing diabetes is simpler, less intrusive, and more empowering than ever before. This innovative, non- invasive device represents not just a technical achievement but a meaningful shift in how individuals can engage with and manage their condition.
By eliminating the need for needles and offering real-time glucose data through a discreet, wearable solution, Glucowear addresses both the physical and emotional challenges of traditional monitoring methods. Its arrival signals a new era in diabetes management, one that prioritises simplicity, comfort, and empowerment, giving people greater freedom to live their lives without compromise.
This work is licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
